ANG Lifesciences India share news and announcements
BSE: 540694Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹34.15.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹43 Cr3,715th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 0.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −22.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −6.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 1.47
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,136
ANG Lifesciences India share news and announcements
374 announcements, routine notices left out, newest first. Page 5 of 8.
Nov 2021
16 Nov · Disclosure Under Regulation 30 Of SEBI LODR, 2015.
12 Nov · Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
2 Nov · Intimation Of In-Principal Approval In Regards To Migration From BSE SME Platform To Main Board Of BSE Ltd.
Oct 2021
30 Oct · Certificate Pursuant To Regulation 40(9) Of Securities Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30.09.2021
28 Oct · Reg. 34 (1) Annual Report
25 Oct · ANG Lifesciences India Limited Reports An EBIDTA Of INR 49.09 Cr For H1 FY22'
25 Oct · Announcement under Regulation 30 (LODR)-Meeting Updates
25 Oct · Board meeting
21 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....20 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 01 Oct · Board meeting
Meeting on 25 Oct 2021: half yearly results, interim dividend, dividend and annual general meeting
Sep 2021
24 Sep · Announcement under Regulation 30 (LODR)-Meeting Updates
13 Sep · Disclosure Under Reg. 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 - Achievement Of Milestone Of Revenue Of Rs. 200 Cr.
11 Sep · Results
Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2021
11 Aug · Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
6 Aug · Corporate action
6 Aug · Board meeting
Jul 2021
30 Jul · Board meeting
Meeting on 6 Aug 2021: increase in authorised capital and bonus issue24 Jul · Announcement under Regulation 30 (LODR)-Meeting Updates
12 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 05 Jul · Announcement Under Reg. 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 - Achievement Of Revenue In First Quarter Of F. Y. 2021-22
Jun 2021
24 Jun · Board meeting
Meeting on 30 Jun 2021: audited results
Apr 2021
22 Apr · Compliances- Certificate By PCS Under Reg. 49(10) Of SEBI (LODR), 2016
21 Apr · Compliances- Compliance Certificate For The Period Ended March, 2021
17 Apr · Shareholding for the Period Ended March 31, 2021
Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....